| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $45,150,986 ) (Continued on the next page) |
| | 2024 | 2024 | ANN & ROBERT H LURIE CHILDRENS HOSPITAL OF CHICAGO | 225 E CHICAGO AVE | CHICAGO | IL | 60611-2991 | COOK | USA | K23DK138313 | Advancing the Approach to Subclinical Diastolic Dysfunction in Youth with Chronic Kidney Disease | 000 | 1 | NIH | 2/16/2024 | $191,143 |
| | 2024 | 2024 | ANN & ROBERT H LURIE CHILDRENS HOSPITAL OF CHICAGO | 225 E CHICAGO AVE | CHICAGO | IL | 60611-2991 | COOK | USA | K08DK132456 | The Unfolded Protein Response in Murine and Pediatric Cholestatic Liver Diseases | 000 | 1 | NIH | 3/15/2024 | $164,452 |
| | 2024 | 2024 | ANN & ROBERT H LURIE CHILDRENS HOSPITAL OF CHICAGO | 225 E CHICAGO AVE | CHICAGO | IL | 60611-2991 | COOK | USA | R01HL167876 | Interpregnancy as a Critical Period for Maternal-Child Cardiovascular Health in Pediatric Clinics: Ancillary to Young Hearts | 001 | 1 | NIH | 5/3/2024 | $23,054 |
| | 2024 | 2024 | ANN & ROBERT H LURIE CHILDRENS HOSPITAL OF CHICAGO | 225 E CHICAGO AVE | CHICAGO | IL | 60611-2991 | COOK | USA | R01HL167876 | Interpregnancy as a Critical Period for Maternal-Child Cardiovascular Health in Pediatric Clinics: Ancillary to Young Hearts | 000 | 1 | NIH | 2/9/2024 | $724,079 |
| | 2024 | 2024 | ANN & ROBERT H LURIE CHILDRENS HOSPITAL OF CHICAGO | 225 E CHICAGO AVE | CHICAGO | IL | 60611-2991 | COOK | USA | R01HD112321 | Measuring and Mapping National Pediatric Acute Care Outcomes | 001 | 2 | NIH | 7/1/2024 | $416,327 |
| | 2024 | 2024 | ANN & ROBERT H LURIE CHILDRENS HOSPITAL OF CHICAGO | 225 E CHICAGO AVE | CHICAGO | IL | 60611-2991 | COOK | USA | K23MH129575 | Iteratively developing and testing a brief, engagement focused intervention for parents and educators: Parent Education Action Response (PEAR) | 001 | 2 | NIH | 8/29/2024 | $152,852 |
| | 2024 | 2024 | ANN & ROBERT H LURIE CHILDRENS HOSPITAL OF CHICAGO | 225 E CHICAGO AVE | CHICAGO | IL | 60611-2991 | COOK | USA | R21AI174116 | Identification of the antigenic targets of the clonal antibody response to Clostridioides difficile infection | 000 | 2 | NIH | 5/31/2024 | $204,393 |
| | 2024 | 2024 | ANN & ROBERT H LURIE CHILDRENS HOSPITAL OF CHICAGO | 225 E CHICAGO AVE | CHICAGO | IL | 60611-2991 | COOK | USA | R01HL168672 | Elucidating the role of type I interferon signaling and macrophage-derived inflammation in the juvenile host with viral pneumonia | 001 | 2 | NIH | 6/18/2024 | $50,615 |
| | 2024 | 2024 | ANN & ROBERT H LURIE CHILDRENS HOSPITAL OF CHICAGO | 225 E CHICAGO AVE | CHICAGO | IL | 60611-2991 | COOK | USA | R01HL168672 | Elucidating the role of type I interferon signaling and macrophage-derived inflammation in the juvenile host with viral pneumonia | 000 | 2 | NIH | 2/1/2024 | $569,413 |
| | 2024 | 2024 | ANN & ROBERT H LURIE CHILDRENS HOSPITAL OF CHICAGO | 225 E CHICAGO AVE | CHICAGO | IL | 60611-2991 | COOK | USA | R01HL163692 | Derivation and Validation of the Pediatric Community-Acquired Pneumonia Severity (PedCAPS) Score | 001 | 2 | NIH | 6/19/2024 | $96,546 |
| | 2024 | 2024 | ANN & ROBERT H LURIE CHILDRENS HOSPITAL OF CHICAGO | 225 E CHICAGO AVE | CHICAGO | IL | 60611-2991 | COOK | USA | R01HL163692 | Derivation and Validation of the Pediatric Community-Acquired Pneumonia Severity (PedCAPS) Score | 000 | 2 | NIH | 2/14/2024 | $1,086,137 |
| | 2024 | 2024 | ANN & ROBERT H LURIE CHILDRENS HOSPITAL OF CHICAGO | 225 E CHICAGO AVE | CHICAGO | IL | 60611-2991 | COOK | USA | R01HL164773 | Investigating structural and genetic substrates of early-onset atrial fibrillation | 000 | 2 | NIH | 5/10/2024 | $499,842 |
| | 2024 | 2024 | ANN & ROBERT H LURIE CHILDRENS HOSPITAL OF CHICAGO | 225 E CHICAGO AVE | CHICAGO | IL | 60611-2991 | COOK | USA | K23HD113816 | Predicting Clinical Deterioration in Mechanically Ventilated Children using High-Frequency Physiologic Data | 000 | 1 | NIH | 8/12/2024 | $163,080 |
| | 2024 | 2024 | ANN & ROBERT H LURIE CHILDRENS HOSPITAL OF CHICAGO | 225 E CHICAGO AVE | CHICAGO | IL | 60611-2991 | COOK | USA | R01HL164570 | Long-term Endotypes of Prematurity Associated Respiratory Disease (LEOPARD) | 000 | 1 | NIH | 8/13/2024 | $2,070,206 |
| | 2024 | 2024 | ANN & ROBERT H LURIE CHILDRENS HOSPITAL OF CHICAGO | 225 E CHICAGO AVE | CHICAGO | IL | 60611-2991 | COOK | USA | R01HL160921 | Hyperglycemia and Adverse Pregnancy Outcome Study-Cardiovascular Health of HAPO Offspring (HAPO CVH) | 002 | 2 | NIH | 6/21/2024 | $150,586 |
| | 2024 | 2024 | ANN & ROBERT H LURIE CHILDRENS HOSPITAL OF CHICAGO | 225 E CHICAGO AVE | CHICAGO | IL | 60611-2991 | COOK | USA | R01HL160921 | Hyperglycemia and Adverse Pregnancy Outcome Study-Cardiovascular Health of HAPO Offspring (HAPO CVH) | 001 | 2 | NIH | 4/25/2024 | $0 |
| | 2024 | 2024 | ANN & ROBERT H LURIE CHILDRENS HOSPITAL OF CHICAGO | 225 E CHICAGO AVE | CHICAGO | IL | 60611-2991 | COOK | USA | R01HL160921 | Hyperglycemia and Adverse Pregnancy Outcome Study-Cardiovascular Health of HAPO Offspring (HAPO CVH) | 000 | 2 | NIH | 3/2/2024 | $1,694,117 |
| | 2024 | 2024 | ANN & ROBERT H LURIE CHILDRENS HOSPITAL OF CHICAGO | 225 E CHICAGO AVE | CHICAGO | IL | 60611-2991 | COOK | USA | P50FD007963 | The Consortium for Technology & Innovation in Pediatrics: CTIP 3.0 | 001 | 2 | FDA | 9/7/2024 | $1,150,000 |
| | 2024 | 2024 | ANN & ROBERT H LURIE CHILDRENS HOSPITAL OF CHICAGO | 225 E CHICAGO AVE | CHICAGO | IL | 60611-2991 | COOK | USA | R18HS029638 | The SafeCare@Home4Kids Learning Lab: Designing Safer Healthcare at Home for Children | 000 | 2 | AHRQ | 6/21/2024 | $480,259 |
| | 2024 | 2024 | ANN & ROBERT H LURIE CHILDRENS HOSPITAL OF CHICAGO | 225 E CHICAGO AVE | CHICAGO | IL | 60611-2991 | COOK | USA | R18HS028783 | Newborn Circumcision Care Redesign | 000 | 3 | AHRQ | 7/15/2024 | $392,765 |
| | 2024 | 2024 | ANN & ROBERT H LURIE CHILDRENS HOSPITAL OF CHICAGO | 225 E CHICAGO AVE | CHICAGO | IL | 60611-2991 | COOK | USA | F30HD107966 | Understanding the microenvironment of the pediatric ovary across the pubertal transition: implications for fertility | 000 | 3 | NIH | 8/5/2024 | $19,031 |
| | 2024 | 2024 | ANN & ROBERT H LURIE CHILDRENS HOSPITAL OF CHICAGO | 225 E CHICAGO AVE | CHICAGO | IL | 60611-2991 | COOK | USA | H79TI085008 | Reaching Every Adolescent in Chicago through Harm reduction (REACH) | 001 | 3 | SAMHSA | 7/18/2024 | $375,000 |
| | 2024 | 2024 | ANN & ROBERT H LURIE CHILDRENS HOSPITAL OF CHICAGO | 225 E CHICAGO AVE | CHICAGO | IL | 60611-2991 | COOK | USA | R01DC019387 | Neural Prediction to Enhance Language Outcomes in Children with Cochlear Implant | 000 | 3 | NIH | 8/9/2024 | $602,156 |
| | 2024 | 2024 | ANN & ROBERT H LURIE CHILDRENS HOSPITAL OF CHICAGO | 225 E CHICAGO AVE | CHICAGO | IL | 60611-2991 | COOK | USA | R01HL164014 | Negative regulators of endothelial regeneration in aging lungs and ARDS | 001 | 3 | NIH | 6/24/2024 | $53,494 |
| | 2024 | 2024 | ANN & ROBERT H LURIE CHILDRENS HOSPITAL OF CHICAGO | 225 E CHICAGO AVE | CHICAGO | IL | 60611-2991 | COOK | USA | R01HL164014 | Negative regulators of endothelial regeneration in aging lungs and ARDS | 000 | 3 | NIH | 4/13/2024 | $601,820 |
| | 2024 | 2024 | ANN & ROBERT H LURIE CHILDRENS HOSPITAL OF CHICAGO | 225 E CHICAGO AVE | CHICAGO | IL | 60611-2991 | COOK | USA | K23AI159517 | Infant Peanut Allergy Prevention: Understanding and Supporting Caregivers to Achieve Adherence | 000 | 3 | NIH | 6/20/2024 | $190,080 |
| | 2024 | 2024 | ANN & ROBERT H LURIE CHILDRENS HOSPITAL OF CHICAGO | 225 E CHICAGO AVE | CHICAGO | IL | 60611-2991 | COOK | USA | U01HD110336 | Reverse Engineering the Extracellular Neighborhood to Support the Functional Tissue Unit: A Use Case to Restore Ovarian Function | 001 | 3 | NIH | 8/15/2024 | $390,806 |
| | 2024 | 2024 | ANN & ROBERT H LURIE CHILDRENS HOSPITAL OF CHICAGO | 225 E CHICAGO AVE | CHICAGO | IL | 60611-2991 | COOK | USA | K23HL157615 | Technology-Enhanced Asthma Care in Children at Clinic and Home (TEACCCH) Study | 000 | 3 | NIH | 3/14/2024 | $189,690 |
| | 2024 | 2024 | ANN & ROBERT H LURIE CHILDRENS HOSPITAL OF CHICAGO | 225 E CHICAGO AVE | CHICAGO | IL | 60611-2991 | COOK | USA | R01HL155113 | Physical Activity Measurement in Toddlers | 000 | 3 | NIH | 1/2/2024 | $383,535 |
| | 2024 | 2024 | ANN & ROBERT H LURIE CHILDRENS HOSPITAL OF CHICAGO | 225 E CHICAGO AVE | CHICAGO | IL | 60611-2991 | COOK | USA | UH3HL148318 | 1/2 Allogeneic Human Mesenchymal Stem Cell (MSC) Injection in Patients with Hypoplastic Left Heart Syndrome: A Phase IIb Clinical Trial | 001 | 6 | NIH | 8/6/2024 | $408,351 |
| | 2024 | 2024 | ANN & ROBERT H LURIE CHILDRENS HOSPITAL OF CHICAGO | 225 E CHICAGO AVE | CHICAGO | IL | 60611-2991 | COOK | USA | U01DD001271 | Urologic Management to Preserve Initial Renal Function Protocol for Young Children with Spina Bifida (UMPIRE) | 03 | 5 | CDC | 9/9/2024 | $0 |
| | 2024 | 2024 | ANN & ROBERT H LURIE CHILDRENS HOSPITAL OF CHICAGO | 225 E CHICAGO AVE | CHICAGO | IL | 60611-2991 | COOK | USA | U01DD001271 | Urologic Management to Preserve Initial Renal Function Protocol for Young Children with Spina Bifida (UMPIRE) | 02 | 5 | CDC | 7/17/2024 | $25,000 |
| | 2024 | 2024 | ANN & ROBERT H LURIE CHILDRENS HOSPITAL OF CHICAGO | 225 E CHICAGO AVE | CHICAGO | IL | 60611-2991 | COOK | USA | R34MH133768 | Development and Preliminary Trial of a Digital Transdiagnostic CBT Intervention for Transgender Adolescents | 000 | 1 | NIH | 4/15/2024 | $249,765 |
| | 2024 | 2024 | ANN & ROBERT H LURIE CHILDRENS HOSPITAL OF CHICAGO | 225 E CHICAGO AVE | CHICAGO | IL | 60611-2991 | COOK | USA | 2B2CMS331762 | Neighborhood Integrated Care for Kids (NInCK) | 01 | 5 | CMS | 2/15/2024 | $0 |
| | 2024 | 2024 | ANN & ROBERT H LURIE CHILDRENS HOSPITAL OF CHICAGO | 225 E CHICAGO AVE | CHICAGO | IL | 60611-2991 | COOK | USA | 2B2CMS331762 | Neighborhood Integrated Care for Kids (NInCK) | 04 | 5 | CMS | 6/14/2024 | $0 |
| | 2024 | 2024 | ANN & ROBERT H LURIE CHILDRENS HOSPITAL OF CHICAGO | 225 E CHICAGO AVE | CHICAGO | IL | 60611-2991 | COOK | USA | 2B2CMS331762 | Neighborhood Integrated Care for Kids (NInCK) | 05 | 5 | CMS | 8/13/2024 | $0 |
| | 2024 | 2024 | ANN & ROBERT H LURIE CHILDRENS HOSPITAL OF CHICAGO | 225 E CHICAGO AVE | CHICAGO | IL | 60611-2991 | COOK | USA | 2B2CMS331762 | Neighborhood Integrated Care for Kids (NInCK) | 03 | 5 | CMS | 5/2/2024 | $0 |
| | 2024 | 2024 | ANN & ROBERT H LURIE CHILDRENS HOSPITAL OF CHICAGO | 225 E CHICAGO AVE | CHICAGO | IL | 60611-2991 | COOK | USA | 2B2CMS331762 | Neighborhood Integrated Care for Kids (NInCK) | 02 | 5 | CMS | 5/2/2024 | $0 |
| | 2024 | 2024 | ANN & ROBERT H LURIE CHILDRENS HOSPITAL OF CHICAGO | 225 E CHICAGO AVE | CHICAGO | IL | 60611-2991 | COOK | USA | 2B2CMS331762 | Neighborhood Integrated Care for Kids (NInCK) | 00 | 5 | CMS | 12/15/2023 | $2,000,000 |
| | 2024 | 2024 | ANN & ROBERT H LURIE CHILDRENS HOSPITAL OF CHICAGO | 225 E CHICAGO AVE | CHICAGO | IL | 60611-2991 | COOK | USA | T32HD111386 | Children’s Surgery Methodology And Research Training (C-SMART) | 000 | 1 | NIH | 5/9/2024 | $196,687 |
| | 2024 | 2024 | ANN & ROBERT H LURIE CHILDRENS HOSPITAL OF CHICAGO | 225 E CHICAGO AVE | CHICAGO | IL | 60611-2991 | COOK | USA | R01NR020918 | Using the Fitbit for early detection of Infection and reduction of healthcare utilization after Discharge in Pediatric Surgical Patients | 001 | 2 | NIH | 6/26/2024 | $794,848 |
| | 2024 | 2024 | ANN & ROBERT H LURIE CHILDRENS HOSPITAL OF CHICAGO | 225 E CHICAGO AVE | CHICAGO | IL | 60611-2991 | COOK | USA | K23HL165426 | RSV I-PREP: Improving Evidence-Based Implementation of RSV Immuno-Prophylaxis Within Ethical and Policy Contexts | 000 | 2 | NIH | 4/25/2024 | $168,480 |
| | 2024 | 2024 | ANN & ROBERT H LURIE CHILDRENS HOSPITAL OF CHICAGO | 225 E CHICAGO AVE | CHICAGO | IL | 60611-2991 | COOK | USA | U01PS005270 | RFA-PS-23-001 - Project PrOVIDE: PrEP Optimization Via Implementation, Dissemination, and Evaluation | 00 | 2 | CDC | 7/10/2024 | $1,999,999 |
| | 2024 | 2024 | ANN & ROBERT H LURIE CHILDRENS HOSPITAL OF CHICAGO | 225 E CHICAGO AVE | CHICAGO | IL | 60611-2991 | COOK | USA | R21AI178334 | Investigating the impact of ESBL E. coli colonization on infant microbiome | 000 | 2 | NIH | 7/19/2024 | $195,186 |
| | 2024 | 2024 | ANN & ROBERT H LURIE CHILDRENS HOSPITAL OF CHICAGO | 225 E CHICAGO AVE | CHICAGO | IL | 60611-2991 | COOK | USA | R01DK136207 | Mechanisms of SGLT2 Inhibition in Pediatric NAFLD | 000 | 1 | NIH | 2/19/2024 | $683,996 |
| | 2024 | 2024 | ANN & ROBERT H LURIE CHILDRENS HOSPITAL OF CHICAGO | 225 E CHICAGO AVE | CHICAGO | IL | 60611-2991 | COOK | USA | U1A41738 | Thalassemia | 01 | 4 | HRSA | 7/24/2024 | $0 |
| | 2024 | 2024 | ANN & ROBERT H LURIE CHILDRENS HOSPITAL OF CHICAGO | 225 E CHICAGO AVE | CHICAGO | IL | 60611-2991 | COOK | USA | U1A41738 | Thalassemia | 00 | 4 | HRSA | 4/16/2024 | $175,000 |
| | 2024 | 2024 | ANN & ROBERT H LURIE CHILDRENS HOSPITAL OF CHICAGO | 225 E CHICAGO AVE | CHICAGO | IL | 60611-2991 | COOK | USA | K23MH135206 | Caring Contacts via text message for suicidal adolescents after emergency department discharge | 000 | 1 | NIH | 8/29/2024 | $190,080 |
| | 2024 | 2024 | ANN & ROBERT H LURIE CHILDRENS HOSPITAL OF CHICAGO | 225 E CHICAGO AVE | CHICAGO | IL | 60611-2991 | COOK | USA | R01CA288496 | Optical Genome Mapping As a Novel Diagnostic Approach in Pediatric Brain Tumors | 000 | 1 | NIH | 7/23/2024 | $699,080 |
|
